Articles: 28.04 April 2017

Full content PDFs

Click here to find links to all the PDF articles from this issue of Prescriber

More details...

Recognition and management of acute kidney injury

Acute kidney injury (AKI) is associated with high morbidity and mortality, and early recognition is important. This article discusses the management of AKI in primary care with a focus on medicines optimisation, and describes when referral is necessary

More details...

Biosimilars: ensuring safety in the search for savings

Biosimilars – cheaper versions of biopharmaceuticals produced by competing companies – have the potential to reduce the NHS drugs bill substantially. However, unlike generic drugs, biosimilars are not interchangeable with the original brand, raising safety concerns. Hence pharmacovigilance and prescribing by brand is essential

More details...

Can drug price hikes via debranding be prevented?

Steep price hikes following the debranding of off-patent medicines are becoming increasingly common in the UK, adding hundreds of millions to the NHS drugs bill. But can anything be done to prevent this

More details...

Web design and marketing agency Leamington Spa